GALWAY, IRELAND--January 21, 2025--Written by Martin Lynch, European News Editor for Industrial Info (Galway, Ireland)--Pharma major Novo Nordisk A/S (NYSE:NVO) (Bagsværd, Denmark) has announced that it is investing 8.5 billion Danish kroner (US$1.2 billion) to build a new production facility in Odense, Denmark.

Within this article: Details investment by Novo Nordisk in a new manufacturing plant in Denmark, scale, timeline, success of Ozempic and Wegovy drugs and the impact on its fortunes and related manufacturing investments